Cochlear Limited today announced the next phase in its long-term research and development program towards a totally implantable cochlear implant, with the start of a further clinical feasibility study. The development of totally implantable cochlear implant technology is complex, and a commercially available product is not expected for years; however, it remains a long-term development goal for Cochlear.
Editor’s note: Clinical trials provide no guarantee that a product will be available in a given time frame, or even at all. If you are considering a cochlear implant and have questions about potential future developments, please discuss them with your hearing professional.
The Nucleus® 7 sound processor is now available for recipients with CI24M and CI24R implants. Ask your audiologist for details!
MED-EL announced today the US Food and Drug Administration (FDA) approval of the RONDO 2 cochlear implant audio processor. Just place the RONDO 2 on the charge pad and it will charge automatically without wires or cables. The rechargeable battery provides up to 18 hours of battery life, and recharges after four hours.
Product availability is estimated in Fall 2018. For more information, read the press release here.
MED-EL is offering new US recipients a voucher for a free RONDO 2, which can be exchanged for the processor when it becomes available, estimated Fall 2018.
The US FDA has approved the FLEXSOFT array, which has been available in other markets, for sale in the United States.
This array is the same length as the CLASSIC series, but designed to be atraumatic.
Advanced Bionics announces the availability of the Naída CI Q90 Acoustic Earhook for Naída CI Q90 recipients in the US and Canada. With the simple addition of the acoustic earhook, the Naída CI Q90 sound processor can deliver acoustic amplification in combination with electrical stimulation to help maximize your hearing experience. Intended for CI candidates and recipients who may benefit from acoustic amplification, the Naída CI Q90 Acoustic Earhook is an all-in-one solution that extends AB’s portfolio for individuals with severe-to-profound hearing loss.
Read more here.
Advanced Bionics announces approval in the US and Canada for the Naída CI Q90 Acoustic Earhook. The Acoustic Earhook can be added to a Naída CI Q90 processor to provide additional low-frequency information. If residual hearing decreases to the point where the acoustic information is no longer useful, the Acoustic Earhook can be swapped out for Advanced Bionics T-mic.
The Naída CI Q90 Acoustic Earhook will be made available to a limited number of North American centers in 2017 and will be made generally available in the United States and Canada in January 2018.
The United States FDA has approved a telehealth option to program cochlear implants remotely. This means that recipients who live in remote areas, or are unable to travel to their cochlear implant clinic, may be able to conduct an audiologist visit from home.
Read the FDA announcement here.
This is just the FDA approval. Availability depends on Cochlear – stay tuned!
MED-EL Announces RONDO 2: A True Revolution in Cochlear Implants
RONDO 2 is the first cochlear implant audio processor that can be charged wirelessly. This ground-breaking new design takes away the need for disposable batteries, making RONDO 2 the easiest-to-use audio processor ever made.
September 15, 2017 — (Innsbruck, Austria) — MED-EL, leading provider of hearing loss solutions, has launched the first cochlear implant audio processor with wireless charging.
Powering up RONDO 2 couldn’t be easier. Users simply have to place it on the charging pad and it will charge automatically. Each 4 hour charge gives an exceptional 18 hours of battery life—in other words, a full day of hearing from one overnight charge.
This simple design means that for the first time, cochlear implant users will not have to deal with the hassles of changing batteries or adjusting their processor. They can just put on RONDO 2 each morning, and then forget about it for the rest of the day.
“We’re so used to charging our mobile devices at home overnight,” says Gregor Dittrich, Director of Product Management at MED-EL. “You charge your phone and tablet in this way, so why not your audio processor? It’s the next logical step for cochlear implants and we’re so excited to be pioneering the way forward”.
RONDO 2’s single-unit design is sleeker and more streamlined than ever before. It is perfect to wear with glasses or hide completely under hair. With the interchangeable Design Covers, users can also make RONDO 2 blend in with their natural hair colour, or match their own unique style.
And of course, with waterproof covers, and Bluetooth accessories for easy connectivity with phones—RONDO 2 is ideal for a busy, modern lifestyle.
RONDO 2 will be available from the beginning of 2018, depending on country. Visit rondo2.medel.com for more information.
In honor of National Grandparent’s Day on September 10, MED-EL USA released new survey results today that indicate a growing acceptance of conversations surrounding hearing loss. The survey also found that family members and major life events would play a key role in motivating people with hearing loss or difficulty hearing to have their hearing checked. Survey highlights include:
- Nearly half of Americans – 46% – know someone with hearing loss or difficulty hearing, and 64% have had a conversation with that person about it
- 83% of adults said that they would feel comfortable talking with someone they knew if they thought they may be experiencing hearing loss or difficulty hearing, signaling a potential shift in overcoming stigma that has traditionally surrounded hearing loss
- 79% of adults 65 and over said that if a family member or loved one approached them about having their hearing checked because they were experiencing hearing loss or difficulty hearing it would motivate them to do so
- 66% of Americans said that a major life event (e.g., marriage, birth of a child/grandchild, health scare) would motivate them to get their hearing checked if they were experiencing hearing loss or difficulty hearing